# Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation

> **NCT01557075** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 2000 (estimated)

## Conditions studied

- Drug-eluting Stent (DES)

## Interventions

- **DRUG:** Atorvastatin (High dose statin treatment)
- **DRUG:** Pravastatin (High dose statin treatment)

## Key facts

- **NCT ID:** NCT01557075
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557075, "Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01557075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*